Delamanid susceptibility testing ofMycobacterium tuberculosisusing the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system

Delamanid and Bedaquiline Resistance inMycobacterium tuberculosisAncestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee

(2016) Harald Hoffmann et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Determination of MIC Distribution and Epidemiological Cutoff Values for Bedaquiline and Delamanid in Mycobacterium tuberculosis Using the MGIT 960 System Equipped with TB eXiST

(2015) Peter M. Keller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients

(2015) A. Van Deun et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data

(2015) Silke Feuerriegel et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The ambition of the European Respiratory Journal: chapter 3

(2015) M. Humbert et al.   EUROPEAN RESPIRATORY JOURNAL

High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

(2015) Abraham J. Niehaus et al.   PLoS One

Mechanism of Action of 5-Nitrothiophenes against Mycobacterium tuberculosis

(2014) R. C. Hartkoorn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis

(2014) Hannah A. Blair et al.   DRUGS

Delamanid: First Global Approval

(2014) Nicola J. Ryan et al.   DRUGS

Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China

(2014) Z. Zhang et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Pipeline of drugs for related diseases

(2013) Kelly E. Dooley et al.   Current Opinion in HIV and AIDS

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

(2012) Vija Skripconoka et al.   EUROPEAN RESPIRATORY JOURNAL

New drugs for the treatment of tuberculosis: hope and reality [State of the Art Series. New tools. Number 2 in the series]

(2012) J. H. Grosset et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

(2012) Maria Tarcela Gler et al.   NEW ENGLAND JOURNAL OF MEDICINE

New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations

(2012) Seidu Malik et al.   PLoS One

High Resolution Discrimination of Clinical Mycobacterium tuberculosis Complex Strains Based on Single Nucleotide Polymorphisms

(2012) Susanne Homolka et al.   PLoS One

Impact offgd1andddnDiversity in Mycobacterium tuberculosis Complex onIn VitroSusceptibility to PA-824

(2011) Silke Feuerriegel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

EUCAST expert rules in antimicrobial susceptibility testing

(2011) R. Leclercq et al.   CLINICAL MICROBIOLOGY AND INFECTION

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

(2011) A. H. Diacon et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay

(2011) P. A. Z. Campanerut et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Metabolic Engineering of Cofactor F420 Production in Mycobacterium smegmatis

(2010) Ghader Bashiri et al.   PLoS One

Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results

(2009) A. Van Deun et al.   JOURNAL OF CLINICAL MICROBIOLOGY